购物车
- 全部删除
- 您的购物车当前为空
Mutated EGFR-IN-1 (Osimertinib analog) 是用于突变 EGFR 抑制剂设计的有用中间体,例如 L858R EGFR、Exon19 缺失激活突变体和 T790M 抗性突变体。
为众多的药物研发团队赋能,
让新药发现更简单!
Mutated EGFR-IN-1 (Osimertinib analog) 是用于突变 EGFR 抑制剂设计的有用中间体,例如 L858R EGFR、Exon19 缺失激活突变体和 T790M 抗性突变体。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 153 | 现货 | |
10 mg | ¥ 225 | 现货 | |
25 mg | ¥ 293 | 现货 | |
50 mg | ¥ 377 | 现货 | |
100 mg | ¥ 503 | 现货 | |
500 mg | ¥ 1,150 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 276 | 现货 |
产品描述 | Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant. |
体外活性 | 突变的EGFR抑制剂作为egfr调节剂,在治疗癌症方面显示出效用。 |
别名 | Osimertinib analog, AZD9291中间体1 |
分子量 | 445.56 |
分子式 | C25H31N7O |
CAS No. | 1421372-66-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 7.5 mg/mL (16.83 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.